Switch to:
GuruFocus articles
Headlines from internet
Oct-20-17$87.75 (-0.43%)
11:42AMDaily Pharma Scoop Johnson And Johnsons Mixed Signals Celgenes Mongersen Failure Qures Seekingalpha
Oct-19-17$88.13 (-0.55%)
08:00AMZacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Valeant Pharmaceuticals International, Teva Pharmaceuticals and Sanofi Zacks
07:40AMMarket Waiting Tax Reform Cramers Mad Money 10 18 17 Seekingalpha
Oct-18-17$88.62 (-5.26%)
08:39PMBioMarin Pharmaceutical: Cramer's Top Takeaways theStreet
06:55PMRally's Not Waiting on Tax Reform: Cramer's 'Mad Money' Recap theStreet
03:59PMPricing Pressure, Competition Remain Headwinds for Pharma Stocks Zacks
Oct-16-17$94.66 (-0.48%)
01:00PMDaily Pharma Scoop Acrx Second Chance Aeri Rhopressa Success Aratana Entyce Launch Seekingalpha
Oct-13-17$95.12 (-0.01%)
03:44PMSpark Therapeutics’ promising gene therapy for vision loss could cost $1 million MarketWatch
12:31PMGene Therapies: A Foot in the Door Barron's
Oct-10-17$94.33 (-0.73%)
09:23AMDaily Pharma Scoop Synergys Cash Position Flexions Zilretta Approval Keryx Major Catalyst Seekingalpha
Oct-09-17$95.02 (+0.22%)
12:23PMSarepta: An OK from the FDA? Barron's
Sep-26-17$93.2 (-1.26%)
02:25PMBombs May Nuke Portfolio Seekingalpha
Sep-10-17
08:00AM3 Things Biotech Learn Today September 10 2017 Seekingalpha
Sep-02-17
08:00AM3 Things In Biotech You Should Learn Today: September 2, 2017 Seekingalpha
Aug-25-17$81.88 (-0.69%)
11:13AMRoche Is Almost At The Finish Line Seekingalpha
Aug-10-17$81.96 (-3.76%)
10:07AMLooking Beyond Factors In Hemophilia Seekingalpha
Aug-02-17$87.64 (-0.43%)
11:18PMSpark Therapeutics' Hemophilia A Data Intriguing, Rise In Shares Overdone Seekingalpha
Aug-01-17$88.02 (+0.33%)
01:02PM2 More Bold Biotech Predictions For The Rest Of 2017 Seekingalpha
Jul-25-17$88.63 (-1.53%)
05:33PMDon't Lose The Faith In Shire Seekingalpha
03:03PMUltragenyx More Than Meets The Eye? Seekingalpha
Jul-20-17$87.74 (+0.58%)
11:40AMLooking For Value In The Deal Sweet Spot Seekingalpha
Jul-12-17$89.57 (-1.48%)
09:02AMBioMarin Pharmaceutical (BMRN) Reports Interim Results From Phase 1/2 BMN 270 Clinical Prog... Seekingalpha
Jul-11-17$90.92 (+1.25%)
05:03PMBiomarin Hemophila A Candidates Looks To Impress The Community Seekingalpha
10:32AMBiotech Forum Daily Digest - FDA Blesses Amicus Therapeutics.  Ocular Therapeutix Rebounds Seekingalpha
Jul-05-17$92.01 (+1.66%)
06:00AM3 Things In Biotech You Should Learn Today: July 5, 2017 Seekingalpha
May-12-17$89.85 (+0.6%)
09:18AMSangamo's Gene Therapy Gets Pfizer Stamp Of Approval Seekingalpha
May-02-17$95.93 (-1.72%)
08:08PMFlurry Of FDA Activity Raises Hopes For 2017 Approval Tally Seekingalpha
Apr-28-17$95.84 (-0.44%)
03:53PMBiomarin And The $702,000 Question Seekingalpha
Apr-25-17$94.19 (+0.72%)
10:30AMBioMarin Races Towards Next Rare Disease Approval Seekingalpha
Apr-07-17$87.95 (+1.22%)
03:21PMBiomarin's Rare Disease Approval And Probiodrug's Alzheimer's Play Seekingalpha


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK